I'm 18 years old and I'm planning on using hygetropin to help increase muscle mass and height. Will I get results that I desire? I'm currently 5'7" and haven't grown since I was 15.
Announcement
Collapse
No announcement yet.
Hygetropin effects on height
Collapse
X
-
A person stops growing when the growth plates in the bones close, which is medically known as "skeletal maturity." Typically this is 16-18 for girls and 18-20 for boys. Bones in the foot generally mature about 2 years sooner than the long bones that affect height. Keep in mind that these are averages, so some people are on the very high or low ends of the spectrum.
You can ask your doctor to examin the fusion of the epiphysial plates. If they are not fused yet, GH and or Oxandrolone can help you grow, if you ask your doctor can help you if you convince him that you have mental issues being small.
Studies on anabolic steroids. IV. Effects of oxandrolone on height and skeletal maturation in uncomplicated growth retardation
Authors: Limbeck GA Ruvalcaba RHA Mahoney CP Kelley VC
Source: Clin. Pharmacol. Ther.; VOL 12 ISS Sep-Oct 1971, P798-805, (REF 9)
Abstract:
ASHP Data are reported on oxandrolone (0.25 mg./kg./day) as a growth-promoting agent in 28 children with uncomplicated growth retardation. The effects on height and skeletal maturation suggest that it has advantages over other anabolic agents. The mean rate of linear growth was approximately doubled, and the mean advance in height age was accelerated more than was the mean advance in skeletal maturation. The former observation demonstrates that oxandrolone is an effective growth promoting drug, while the latter suggests that the childrens' ultimate adult heights may not be compromised because of the administration of this anabolic steroid.
Six-year results of a randomized, prospective trial of human growth hormone and oxandrolone in Turner syndrome
Authors:
Rosenfeld RG Frane J Attie KM Brasel JA Johanson AJ et al
Source: J. Pediatr.; VOL 121 ISS Jul 1992, P49-55, (REF 24)
Abstract:
ASHP To determine the effect of treatment on growth velocity and adult height, 62 girls (ages 4.7-12.4 yr) with Turner's syndrome were randomly assigned to 1 of 4 treatments for a period of 3 to 6 yr: (1) no therapy, (2) 0.125 mg/kg/day of oxandrolone, (3) 0.125 mg/kg of somatropin (human growth hormone) 3 times/wk, and (4) combination of oxandrolone and somatropin at the same doses. When compared with the anticipated growth rate in untreated patients, the growth rate after treatment with somatropin, both alone and in combination with oxandrolone, showed a sustained increase for at least 6 yr. Fourteen (82%) of 17 girls receiving somatropin alone and 41 (91%) of 45 girls receiving combination therapy exceeded their expected adult heights. Thirty girls completed treatment; their mean height was 151.9 cm, compared with the mean original projected adult height of 143.8 cm. It was concluded that therapy with somatropin, alone and in combination with oxandrolone, can result in a sustained increase in growth rate and a significant increase in adult height for most prepubertal girls with Turner's syndrome.
Comment
Comment